You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Impetigo

Showing 1 - 25 of 451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acne Vulgaris, Impetigo, Folliculitis Trial (Ialuxid gel)

Not yet recruiting
  • Acne Vulgaris
  • +2 more
  • Ialuxid gel
  • (no location specified)
Apr 26, 2022

Cellulitis, Abscess, Drain Abscess Trial in Columbus (Default Duration order Panel)

Recruiting
  • Cellulitis
  • +6 more
  • Default Duration order Panel
  • Columbus, Ohio
    Nationwide Children's Hospital Primary Care Clinics
Jul 29, 2022

Impetigo Trial in Spain (Mupirocin gel, Mupirocin ointment, Placebo)

Completed
  • Impetigo
  • Mupirocin gel
  • +2 more
  • Sevilla, Andalucia, Spain
  • +19 more
Mar 9, 2021

Lymphatic Filariases, Scabies, Impetigo Trial in Suva (3 drug dose - IDA, 3 drug dose - IDA with second dose of ivermectin, 2

Completed
  • Lymphatic Filariases
  • +3 more
  • 3 drug dose - IDA
  • +2 more
  • Suva, Fiji
    Ministry of Health and Medical Services
Dec 30, 2020

Scabies, Yaws, Impetigo Trial in Atoifi (Ivermectin, Azithromycin, Permethrin)

Completed
Has Results
  • Scabies
  • +2 more
  • Atoifi, Malaita, Solomon Islands
    Atoifi Adventist Hospital
Sep 13, 2019

Surveillance of Streptococcal Infections in Children in India

Completed
  • Group A Beta Hemolytic Streptococcal (GAS) Infection
    • Chandigarh, India
    • +1 more
    Dec 13, 2019

    Erysipelas, Impetigo, Herpes Zoster Trial in Bergamo (Screening, Tele-dermatology)

    Completed
    • Erysipelas
    • +9 more
    • Screening
    • Tele-dermatology
    • Bergamo, Italy
      Local Health Authority (ATS)
    May 16, 2019

    Impetigo, Secondarily Infected Traumatic Lesions Trial in Anniston, Cape Town (TD1414 2% cream, Bactroban® (mupirocin) 2% cream)

    Completed
    Has Results
    • Impetigo
    • Secondarily Infected Traumatic Lesions
    • TD1414 2% cream
    • Bactroban® (mupirocin) 2% cream
    • Anniston, Alabama
    • +1 more
    Aug 10, 2018

    Secondarily Infected Traumatic Lesions (SITL), Impetigo Trial in College Station (2% TD1414 Cream)

    Completed
    Has Results
    • Secondarily Infected Traumatic Lesions (SITL)
    • Impetigo
    • 2% TD1414 Cream
    • College Station, Texas
      J&S Studies, Inc.
    Jun 26, 2018

    Failure of Scabies in Autochthonous Populations of French Guiana

    Recruiting
    • Scabies
    • Data collection
    • Cayenne, French Guiana
      General Hospital of Cayenne
    Jun 11, 2021

    Impetigo Trial in South Africa (ATx201, ATx201 GEL Vehicle)

    Completed
    • Impetigo
    • Bloemfontein, South Africa
    • +15 more
    Jul 30, 2018

    "Clinical and Epidemiological Characteristics of Inflammatory

    Completed
    • Inflammatory Rhinitis
    • survey
    • Nantes, France
      University Hospital
    Jun 7, 2021

    Atopic Dermatitis Trial in Hiroshima (0.3% OPA-15406 ointment, 1% OPA-15406 ointment)

    Completed
    Has Results
    • Atopic Dermatitis
    • 0.3% OPA-15406 ointment
    • 1% OPA-15406 ointment
    • Hiroshima, Japan
      Shirao clinic of pediatrics and pediatric allergy
    Oct 21, 2021

    SMA Trial in Worldwide (Onasemnogene Abeparvovec-xioi)

    Completed
    Has Results
    • SMA
    • Onasemnogene Abeparvovec-xioi
    • Ghent, Belgium
    • +9 more
    Aug 12, 2022

    Acne Vulgaris Trial in Münster (Benzoyl Peroxide, Dermotivin® Soft Liquid cleanser, Cetaphil® Dermacontrol Moisturizer SPF30)

    Completed
    Has Results
    • Acne Vulgaris
    • Benzoyl Peroxide
    • +2 more
    • Münster, Germany
      EGBERT Mi-Ran
    Feb 16, 2021

    Asthma Trial (montelukast, Comparator: Placebo)

    Completed
    Has Results
    • Asthma
    • (no location specified)
    Jan 31, 2022

    C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)

    Terminated
    Has Results
    • C3 Glomerulonephritis
    • +4 more
    • Birmingham, Alabama
    • +12 more
    Aug 9, 2022

    Atopic Dermatitis Trial in Sapporo (0.3% OPA-15406, 1% OPA-15406, Placebos)

    Completed
    Has Results
    • Atopic Dermatitis
    • 0.3% OPA-15406
    • +2 more
    • Sapporo, Japan
      Kato Dermatology Clinic
    Jan 5, 2021

    Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

    Completed
    Has Results
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • Nagoya, Aichi, Japan
    • +27 more
    Nov 18, 2022

    Hemophilia A Trial in Worldwide (Recombinant coagulation factor (rFVIIIFc))

    Completed
    Has Results
    • Hemophilia A
    • Recombinant coagulation factor (rFVIIIFc)
    • Washington, District of Columbia
    • +11 more
    Feb 21, 2022

    Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

    Active, not recruiting
    Has Results
    • Atypical Hemolytic Uremic Syndrome (aHUS)
    • Ravulizumab
    • Aurora, Colorado
    • +19 more
    Nov 16, 2022

    HIV Trial in Worldwide (Lopinavir/ritonavir)

    Completed
    Has Results
    • HIV
    • La Jolla, California
    • +18 more
    Nov 3, 2021

    Acne Trial in Windsor, Montreal (Adapalene BPO Gel standard daily overnight application, Adapalene-BPO 3-hour daily application

    Completed
    Has Results
    • Acne
    • Adapalene BPO Gel standard daily overnight application
    • +3 more
    • Windsor, Ontario, Canada
    • +1 more
    Feb 16, 2021

    Atopic Dermatitis Trial in Germany, United States (Pimecrolimus, Topical corticosteroids)

    Completed
    Has Results
    • Atopic Dermatitis
    • Phoenix, Arizona
    • +30 more
    Feb 4, 2022

    Molluscum Contagiosum Trial in Lincoln (VP-102 with applicator)

    Completed
    Has Results
    • Molluscum Contagiosum
    • VP-102 with applicator
    • Lincoln, Nebraska
      Midwest Children's Health
    Aug 9, 2021